Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension (vol 62, pg 325, 2015)

JOURNAL OF HEPATOLOGY

卷:67

Correction

Mookerjee, Rajeshwar P.¹  Mehta, Gautam¹  Balasubramaniyan, Vairappan¹  Mohamed, Fatma El Zahraa^1,3  Davies, Nathan¹  Sharma, Vikram¹  Iwakiri, Yasuko²  Jalan, Rajiv¹ 

[1] UCL, Inst Liver & Digest Hlth, Liver Failure Grp, London, England

[2] Yale Univ, Sch Med, Dept Med, Sect Digest Dis, New Haven, CT 06510 USA

[3] Menia Univ, Fac Med, Pathol Dept, Al Minya, Egypt

DOI  :  10.1016/j.jhep.2017.08.004

来源: Elsevier

【 授权许可】

Free